Persistent Systems’ shares declined following disappointing June quarter results, with revenue growth slowing due to healthcare sector sluggishness and project delays. While the company aims for $2 billion revenue by FY27, some analysts consider its valuation high amid short-term challenges. Despite a growing order book, client caution persists, leading to mixed analyst ratings, with some reducing earnings estimates.
​Persistent Systems’ shares declined following disappointing June quarter results, with revenue growth slowing due to healthcare sector sluggishness and project delays. While the company aims for $2 billion revenue by FY27, some analysts consider its valuation high amid short-term challenges. Despite a growing order book, client caution persists, leading to mixed analyst ratings, with some reducing earnings estimates.Â
